[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Apogee Therapeutics, Inc. Common Stock (APGE)
Apogee Therapeutics (APGE) shares surged after positive analyst ratings and the closing of a public offering. The company's eczema drugs are seen as potential rivals to Dupixent, driving investor interest.
About Apogee Therapeutics, Inc. Common Stock
Apogee Therapeutics, Inc. Common Stock (APGE) is a publicly traded stock in the healthcare sector.
Apogee Therapeutics, Inc. Common Stock uses the ticker $APGE for trading. Listed in the Stocks and category.
Insights #
- Apogee Therapeutics, Inc. Common Stock (APGE) trading volume is up XXXXXX% from the previous week.
- Apogee Therapeutics, Inc. Common Stock (APGE) market cap is up XXXXX% from the previous X months.
- Apogee Therapeutics, Inc. Common Stock (APGE) social dominance is up XXXXXX% from the previous month.
- Apogee Therapeutics, Inc. Common Stock (APGE) galaxy score™ is up XXXXXX% from the previous month.
- Apogee Therapeutics, Inc. Common Stock (APGE) sentiment is up XXXXX% from the previous week.
- Apogee Therapeutics, Inc. Common Stock (APGE) engagements is up XXX% from the previous week.
- Apogee Therapeutics, Inc. Common Stock (APGE) posts created is up XXXXX% from the previous week.
Price: $XX #
Price 24-Hour Time-Series Raw Data
The price action is likely driven by a combination of positive analyst ratings, the closing of a public offering, and the potential of its eczema drugs. The initial price drop after the offering was short-lived, and the stock has since recovered, indicating strong investor confidence.
| 24-Hour | 7-Day | 30-Day |
|---|---|---|
| -XXXX% | XXXXX% | XXXXX% |
1-Year High: $XXXXX on 2024-11-08
1-Year Low: $XXXXX on 2025-04-08
AltRank: XXXXX #
AltRank 24-Hour Time-Series Raw Data
Apogee Therapeutics, Inc. Common Stock (APGE) is currently AltRank #1,745 based on combined combined social and market metrics
Daily Average: XXXXX
1 Week: XXX -XXX
1 Month: XXXXX +1,430
6 Months: XXXXX +1,383
1 Year: XXXXX +765
1-Year High: XXXXX on 2025-09-19
1-Year Low: XX on 2025-02-17
Galaxy Score: XXXXX #
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +6
1 Month: XX +23
6 Months: XX -XX
1 Year: XX -XX
1-Year High: XX on 2025-10-08
1-Year Low: XX on 2025-02-11
Engagements: XXXXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
1 Week: XXXXXXX +598%
1 Month: XXXXXXX +24%
6 Months: XXXXXXXXX +112%
1 Year: XXXXXXXXX +92%
1-Year High: XXXXXXX on 2025-07-07
1-Year Low: XXX on 2024-11-06
| Social Network | X |
|---|---|
| Engagements | XXXXX |
Mentions: XX #
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1 Month: XXX -XX%
6 Months: XXXXX +79%
1 Year: XXXXX +204%
1-Year High: XXX on 2025-07-07
1-Year Low: XX on 2025-09-06
| Social Network | X |
|---|---|
| Mentions | XX |
Creators: XX #
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Apogee Therapeutics, Inc. Common Stock (APGE) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
1 Month: XX +2.30%
6 Months: XXXXX +229%
1 Year: XXXXX +238%
1-Year High: XXX on 2025-07-07
1-Year Low: X on 2025-09-06
The most influential creators that mention Apogee Therapeutics, Inc. Common Stock in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @HOThomasWPhelps | X | XXX | X | XXX |
| @HenryHarris666 | X | XXXXX | X | XXX |
| @EzzAl90264 | X | XXX | X | XXX |
| @MSollender | X | XXXXXX | X | XXX |
| @linhnguyen64143 | X | XX | X | XX |
| @HedgeFundTips | X | XXXXXX | X | XX |
| @themarketuni | X | XXXXX | X | XX |
| @seedy19tron | X | XXXXX | X | XX |
| @PikaCapital | X | XXXXX | X | XX |
| @AponiaAnalytics | XX | XXXXX | X | XX |
Sentiment: XX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% +33%
1 Month: XX% +21%
6 Months: XX% -XX%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-10-17
1-Year Low: X% on 2025-01-28
Most Supportive Themes
- Positive Analyst Ratings and Price Targets: (35%) Several analysts have reiterated 'Buy' ratings and provided positive price targets for APGE, contributing to positive sentiment.
- Closing of Public Offering: (25%) The announcement of the closing of a public offering and the exercise of the underwriters' option to purchase additional shares has been met with positive reactions.
- Potential Dupixent Rivalry: (20%) TD Cowen highlighted APGE's eczema drugs as potential rivals to Dupixent, which has generated significant interest.
Most Critical Themes
- Public Offering Concerns: (10%) The public offering, while closed, initially caused a price drop, indicating some investor concern.
- After-Hours Price Drop: (10%) The stock experienced a price decrease after the announcement of the public offering, which may be a concern for some investors.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXX | XX% | XXXXX | XX% | XX | X% |
| Total | XXXXX | XX% | XXXXX | XX% | XX | X% |
Social Dominance: XXXXXXX% #
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
1 Week: XXXXXXX% +0.00629%
1 Month: XXXXX% +0.0094%
6 Months: XXXXX% +0.0037%
1 Year: XXXXX% +0.0003999999999999993%
1-Year High: XXXXX% on 2025-07-07
1-Year Low: XXXXXX% on 2025-09-06
Market Dominance: XXXXXXX% #
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXXXX% on 2024-11-08
1-Year Low: XXXXXXX% on 2025-02-27
Market Cap: $XXXXXXXXXXXXX #
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX +$50%
1 Month: $XXXXXXXXXXXXX +$61%
6 Months: $XXXXXXXXXXXXX +$84%
1 Year: $XXXXXXXXXXXXX +$12%
1-Year High: $XXXXXXXXXXXXX on 2025-10-13
1-Year Low: $XXXXXXXXXXXXX on 2025-04-08
Top assets mentioned In the posts about Apogee Therapeutics, Inc. Common Stock in the last XX hours
Intellia Therapeutics, Inc (NTLA) Diginex Limited Ordinary Shares (DGNX) Akropolis (AKRO) Sanofi (SNY) HSBC Holdings PLC (HSBC) Merus N.V. Common Shares (MRUS) Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) Regeneron Pharmaceuticals Inc (REGN) Regeneron Pharmaceuticals Inc (REGN)
Top topics mentioned In the posts about Apogee Therapeutics, Inc. Common Stock in the last XX hours
stocks healthcare, $ntla, $dgnx, stocks bitcoin treasuries, primary market, stocks consumer cyclical, stocks, $akro, stocks technology, sanofi, $tlry, $hsbc, stocks bitcoin miners, $mrus, $rxrx, regeneron pharmaceuticals inc, $regn, $oklo, stocks industrials, $kymr, investment, $rna, coins defi, coins solana ecosystem, $path, $qure, $abbv, $crvs, united states, $prgo, $cort, $vera, stocks financial services, $apld, $crml, $uamy, $220b, coins layer 1, $eras, $gwrs, $imtx, $atos, $run, $pcvx, $ptct, $rytm, $usar, $barcl, $14b, $nne, $nktr, $asts, $idya, $mdgl, $bntx, $onc, $smmt, $rvmd, $rell, $abus, $abvx, $amlx, $atyr, $bmrn, $amrx, aptiv plc, applied, $spx, $spy, $xbi, $qqq, $hl, brad, $cenx, $ag, stocks utilities, coins bsc, $sedg, $hond, $leu, $csiq, $smr, $mynz, sofi technologies, $sofi, $bull, stocks crypto treasuries, advanced micro devices, $eose, stocks energy, cipher mining, $mur, where is, money, $bdrx, make a, $ionq, $bma, $metc, bank of america
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Ready to find next Tomorrow hottest stocks We're on it this weekendjoin my FREE group where members have already scored gains Get handpicked plays with serious upside potential (50% to 260%+) My WhatsAppđź”— : $BITF $ASTS $ONDS $APGE $CIFR $BBAI"
X Link @HenryHarris666 2025-10-14T21:38Z 1910 followers, XXX engagements
"I've created a WhatsApp group. I'll share the latest stock market trends and investment strategies there. I'll also carefully select high-quality stocks and post them to the group daily. 👉Join now: $APGE $CIFR $BITF $ASTS $ONDS"
X Link @HenryHarris666 2025-10-14T13:12Z 1910 followers, XXX engagements
"$GWAV BUY XX TP1 XXXXX TP2 STOP XXXXX $DAL $OKLO $ALB $MP $IREN $RELL $TLRY $AKRO $NGNE $BJDX $USAR $UAL $SERV $BYRN $RACE $TSLA $AZZ $HELE $APGE $HSBC $TM"
X Link @mohamedtrade45 2025-10-14T09:07Z XX followers, XXX engagements
"$CRVS Barclays OW PT$16 view of a positive risk-reward for Corvus' ITK inhibitor soquelitinib (CPI-818) ahead of atopic dermatitis (AD) data this quarter as believe soqueltinib has a differentiated mechanism of action with early clinical data that suggests clinical benefit in AD. Upside case USD XXXXX Our upside scenario reflects data in atopic dermaitis above our expectations"
X Link @semodough 2025-10-13T14:28Z 41.4K followers, 19.9K engagements